Transglutaminase-2 Regulates Wnt and FoxO3a Signaling to Determine the Severity of Osteoarthritis

Overview

Journal Sci Rep

Specialty Science

Date 2020 Aug 9

PMID 32764573

Citations 5

Authors

Min-Su Han

Youn-Kwan Jung

Gun-Woo Kim

Seungwoo Han

Affiliations

Soon will be listed here.

Abstract

Transglutaminase 2 (TG2), also known as tissue transglutaminase, is a calcium-dependent enzyme that has a variety of intracellular and extracellular substrates. TG2 not only increases in osteoarthritis (OA) tissue but also affects the progression of OA. However, it is still unclear how TG2 affects cartilage degradation in OA at the molecular level. Surgically induced OA lead to an increase of TG2 in the articular cartilage and growth plate, and it was dependent on TGFβ1 in primary chondrocytes. The inhibition of TG2 enzymatic activity with intra-articular injection of ZDON, the peptide-based specific TG2 inhibitor, ameliorated the severity of surgically induced OA as well as the expression of MMP-3 and MMP-13. ZDON attenuated MMP-3 and MMP-13 expression in TGFβ- and calcium ionophore-treated chondrocytes in a Runx2-independent manner. TG2 inhibition with ZDON suppressed canonical Wnt signaling through a reduction of β-catenin, which was mediated by ubiquitination-dependent proteasomal degradation. In addition, TG2 activation by a calcium ionophore enhanced the phosphorylation of AMPK and FoxO3a and the nuclear translocation of FoxO3a, which was responsible for the increase in MMP-13. In conclusion, TG2 plays an important role in the pathogenesis of OA as a major catabolic mediator that affects the stability of β-catenin and FoxO3a-mediated MMP-13 production.

Citing Articles

The Roles of Forkhead Box O3a (FOXO3a) in Bone and Cartilage Diseases - A Narrative Review.

Wu Z, Zhan W, Wu L, Yu L, Xie X, Yu F Drug Des Devel Ther. 2025; 19:1357-1375.

PMID: 40034405 PMC: 11874768. DOI: 10.2147/DDDT.S494841.

Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines.

Lahusen A, Minhofer N, Lohse K, Blechner C, Lindenmayer J, Eiseler T J Immunother Cancer. 2025; 13(1.

PMID: 39824529 PMC: 11748943. DOI: 10.1136/jitc-2024-010579.

GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma.

Ganesh R, Venkataraman K, Sirdeshmukh R J Cell Commun Signal. 2023; 17(4):1527-1535.

PMID: 37980704 PMC: 10713905. DOI: 10.1007/s12079-023-00792-5.

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling.

Liu F, Wu M, Wu X, Chen D, Xie M, Pan H J Orthop Surg Res. 2023; 18(1):168.

PMID: 36872331 PMC: 9985845. DOI: 10.1186/s13018-023-03656-1.

Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme.

Rossin F, Ciccosanti F, DEletto M, Occhigrossi L, Fimia G, Piacentini M Cell Mol Life Sci. 2023; 80(2):52.

PMID: 36695883 PMC: 9874183. DOI: 10.1007/s00018-023-04698-8.

References

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

Tchetina E, Kobayashi M, Yasuda T, Meijers T, Pidoux I, Robin Poole A . Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis. Matrix Biol. 2007; 26(4):247-58. DOI: 10.1016/j.matbio.2007.01.006. View

Little C, Barai A, Burkhardt D, Smith S, Fosang A, Werb Z . Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 2009; 60(12):3723-33. PMC: 2832925. DOI: 10.1002/art.25002. View

Li H, Wang D, Yuan Y, Min J . New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res Ther. 2017; 19(1):248. PMC: 5681770. DOI: 10.1186/s13075-017-1454-2. View

Adamczyk M . Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis. Amino Acids. 2016; 49(3):625-633. PMC: 5332500. DOI: 10.1007/s00726-016-2305-1. View

Lee C, Park H . Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity. Apoptosis. 2017; 22(9):1057-1068. DOI: 10.1007/s10495-017-1396-9. View

Bianchi N, Beninati S, Bergamini C . Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects. Biochem J. 2018; 475(9):1643-1667. DOI: 10.1042/BCJ20170601. View

Lai T, Lin C, Greenberg C . Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes. Amino Acids. 2016; 49(3):501-515. DOI: 10.1007/s00726-016-2270-8. View

Johnson K, Terkeltaub R . External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem. 2005; 280(15):15004-12. DOI: 10.1074/jbc.M500962200. View

10.

Orlandi A, Oliva F, Taurisano G, Candi E, Di Lascio A, Melino G . Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids. 2008; 36(4):755-63. DOI: 10.1007/s00726-008-0129-3. View

11.

Jung Y, Han M, Park H, Lee E, Jang J, Kim G . Calcium-phosphate complex increased during subchondral bone remodeling affects earlystage osteoarthritis. Sci Rep. 2018; 8(1):487. PMC: 5765022. DOI: 10.1038/s41598-017-18946-y. View

12.

Jung Y, Park H, Cho H, Jang J, Lee E, Han M . Degrading products of chondroitin sulfate can induce hypertrophy-like changes and MMP-13/ADAMTS5 production in chondrocytes. Sci Rep. 2019; 9(1):15846. PMC: 6825126. DOI: 10.1038/s41598-019-52358-4. View

13.

Park N, Lim K, Han M, Che X, Park C, Kim J . Core Binding Factor β Plays a Critical Role During Chondrocyte Differentiation. J Cell Physiol. 2015; 231(1):162-71. DOI: 10.1002/jcp.25068. View

14.

Goldring S, Goldring M . Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016; 12(11):632-644. DOI: 10.1038/nrrheum.2016.148. View

15.

Zhen G, Wen C, Jia X, Li Y, Crane J, Mears S . Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013; 19(6):704-12. PMC: 3676689. DOI: 10.1038/nm.3143. View

16.

Shen J, Li J, Wang B, Jin H, Wang M, Zhang Y . Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum. 2013; 65(12):3107-19. PMC: 3928444. DOI: 10.1002/art.38122. View

17.

Chen C, Thuillier D, Chin E, Alliston T . Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis. Arthritis Rheum. 2012; 64(10):3278-89. PMC: 3544176. DOI: 10.1002/art.34566. View

18.

Blom A, Brockbank S, van Lent P, van Beuningen H, Geurts J, Takahashi N . Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 2009; 60(2):501-12. DOI: 10.1002/art.24247. View

19.

Zhu M, Tang D, Wu Q, Hao S, Chen M, Xie C . Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res. 2008; 24(1):12-21. PMC: 2640321. DOI: 10.1359/jbmr.080901. View

20.

Hartmann C, Tabin C . Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development. 2000; 127(14):3141-59. DOI: 10.1242/dev.127.14.3141. View